The second annual Psychedelics as Medicine Conference will gather influential researchers and policy makers in Reykjavik, Iceland for a two-day conference.| Lucid News - Psychedelics, Consciousness Technology, and the Future of Wellness
The MAPS nonprofit remains the largest shareholder, but gives up controlling interest in MAPS PBC, as the for-profit company that seeks to commercialize MDMA therapy successfully attracts investors.| Lucid News - Psychedelics, Consciousness Technology, and the Future of Wellness
Lykos Therapeutics addresses concerns from FDA Advisors about MDMA-assisted therapy and presents a forward looking plan.| Lucid News - Psychedelics, Consciousness Technology, and the Future of Wellness
